Chlorhexidine Gluconate Solution at 0.125% vs Placebo for the Healing of Grade IIB Ulcers of Diabetic Foot
Status:
Unknown status
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
There is controversy regarding the utility of antiseptics in wound management for diabetic
foot ulcer syndrome. The aim of this study is to assess chlorhexidine gluconate at 0.125% vs.
saline solution to reduce the ulcerated area in patients with diabetic ulcer syndrome. A
clinical trial model to evaluate modifications in size and area is proposed. Patients to be
included will be those with diabetic foot ulcers Graded II accordingly to the University of
Texas wound classification system.